Worth reading
53Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
75000
SharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock options
Who receives how much
Up to 75,000 common shares of the Company (750 share acquisition rights, 100 shares per right)
2 directors of the Company15,500 shares (155 rights)
3 outside directors of the Company7,000 shares (70 rights)
4 executive officers of the Company9,500 shares (95 rights)
35 employees of the Company32,500 shares (325 rights)
3 directors of the Company's subsidiaries6,000 shares (60 rights)
7 employees of the Company's subsidiaries4,500 shares (45 rights)
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Terms of the stock acquisition rights
Exercise price
The initial exercise price will be the higher of the average closing price on each trading day in June 2026 multiplied by 1.05 and the closing price on the allotment date. Adjustment provisions apply in the event of a share split or consolidation, an issuance of shares at a price below market value, or similar events. The floor for adjustments is Not disclosed.
Exercise period
Start Date 17 June 2029 / End date 16 June 2034
Number of Stock Acquisition Rights
Total number issued 750 rights (planned number of rights to be allotted; this number may decrease if applications are not received or for other reasons) / Unexercised balance Not disclosed
Reason for acquisition without consideration
If a proposal concerning a merger, company split, share exchange, share transfer, conversion into a company whose shares are subject to transfer restrictions, or similar matter is approved at a general meeting of shareholders or resolved by the Board of Directors. Also, if a holder of the share acquisition rights ceases to satisfy the exercise conditions and therefore becomes unable to exercise the rights, or dies.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 2 / Number of rights allotted 155, Category Outside Directors of the Company / Number of Employees 3 / Number of rights allotted 70 rights, Category Executive officers of the Company / Number of Employees 4 / Number of rights allotted 95, Category The Company's employees / Number of Employees 35 / Number of rights allotted 325, Category Directors of the company's subsidiaries / Number of Employees 3 / Number of rights allotted 60, Category Employees of the company's subsidiaries / Number of Employees 7 / Number of rights allotted 45
Basis for determining the amount to be paid
The exercise price of the share acquisition rights will be the average closing price of the Company's common shares in ordinary trading on the Tokyo Stock Exchange during the month preceding the month in which the allotment date falls, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific amount is scheduled to be determined on 1 July 2026. The premium to the average share price is 5%.
Procedures under the Corporate Code of Conduct
At the ninth annual general meeting of shareholders held on 17 June 2026, the proposal titled “Issuance of Share Acquisition Rights as Stock Options” was approved and adopted, and the Board of Directors determined the offering terms at its meeting held today.
Impact on Business Performance
The purpose is to further increase motivation and morale to improve performance and thereby enhance corporate value. The specific impact on operating performance and financial results is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock options |
| Number of shares to be issued or disposed of | Up to 75,000 common shares of the Company (750 share acquisition rights, 100 shares per right) |
| Intended allottee | Name 2 directors of the Company / Number of Shares 15,500 shares (155 rights), Name 3 outside directors of the Company / Number of Shares 7,000 shares (70 rights), Name 4 executive officers of the Company / Number of Shares 9,500 shares (95 rights), Name 35 employees of the Company / Number of Shares 32,500 shares (325 rights), Name 3 directors of the Company's subsidiaries / Number of Shares 6,000 shares (60 rights), Name 7 employees of the Company's subsidiaries / Number of Shares 4,500 shares (45 rights) |
| Basis for determining the amount to be paid | The exercise price of the share acquisition rights will be the average closing price of the Company's common shares in ordinary trading on the Tokyo Stock Exchange during the month preceding the month in which the allotment date falls, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific amount is scheduled to be determined on 1 July 2026. The premium to the average share price is 5%. |
| Exercise price | The initial exercise price will be the higher of the average closing price on each trading day in June 2026 multiplied by 1.05 and the closing price on the allotment date. Adjustment provisions apply in the event of a share split or consolidation, an issuance of shares at a price below market value, or similar events. The floor for adjustments is Not disclosed. |
| Exercise period | Start Date 17 June 2029 / End date 16 June 2034 |
| Number of Stock Acquisition Rights | Total number issued 750 rights (planned number of rights to be allotted; this number may decrease if applications are not received or for other reasons) / Unexercised balance Not disclosed |
| Reason for acquisition without consideration | If a proposal concerning a merger, company split, share exchange, share transfer, conversion into a company whose shares are subject to transfer restrictions, or similar matter is approved at a general meeting of shareholders or resolved by the Board of Directors. Also, if a holder of the share acquisition rights ceases to satisfy the exercise conditions and therefore becomes unable to exercise the rights, or dies. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 2 / Number of rights allotted 155, Category Outside Directors of the Company / Number of Employees 3 / Number of rights allotted 70 rights, Category Executive officers of the Company / Number of Employees 4 / Number of rights allotted 95, Category The Company's employees / Number of Employees 35 / Number of rights allotted 325, Category Directors of the company's subsidiaries / Number of Employees 3 / Number of rights allotted 60, Category Employees of the company's subsidiaries / Number of Employees 7 / Number of rights allotted 45 |
| Procedures under the Corporate Code of Conduct | At the ninth annual general meeting of shareholders held on 17 June 2026, the proposal titled “Issuance of Share Acquisition Rights as Stock Options” was approved and adopted, and the Board of Directors determined the offering terms at its meeting held today. |
| Impact on Business Performance | The purpose is to further increase motivation and morale to improve performance and thereby enhance corporate value. The specific impact on operating performance and financial results is Not disclosed. |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further increase motivation and morale to improve business performance and achieve further enhancement of corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.